Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875131 · ClinicalTrials.gov registry record
Definition, Quantification, and Utility of Biomarkers of Repetitive Brain Injury in Predicting Concussion and Other Long-Term Injury Risks in Patients With Atrial Fibrillation (Concussion AF)
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 120
- Enrollment target
NCT03875131: Completed study, sponsored by Intermountain Health Care.
NCT03875131 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875131 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
This is a prospective clinical study designed to evaluate biomarkers of brain injury and dementia incidence and moderate cognitive decline rates in moderate- to high-risk atrial fibrillation patients that undergo standard of care atrial fibrillation management.
Primary Outcome
For cognitive assessment, the Mini-Mental Status Examination will be administered at the baseline visit and repeated at the 24-month visits. More information can be obtained at http://www.dhs.state.mn.us/main/groups/county\_access/documents/pub/dhs16\_159601.pdf.
Interventions
- OTHER Biomarkers of Dementia and Cognitive Decline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2017-07-15 |
| Est. Completion | 2022-10-24 |
What the finished NCT03875131 record still lists
NCT03875131 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Biomarkers of Dementia and Cognitive Decline is the first listed.
NCT03875131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03875131 about?
NCT03875131 is a clinical study titled "Definition, Quantification, and Utility of Biomarkers of Repetitive Brain Injury in Predicting Concussion and Other Long-Term Injury Risks in Patients With Atrial Fibrillation (Concussion AF)". This is a prospective clinical study designed to evaluate biomarkers of brain injury and dementia incidence and moderate cognitive decline rates in moderate- to high-risk atrial fibrillation patients that undergo standard of care atrial fibrillation management.
What is the current status of trial NCT03875131?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2017-07-15. Estimated completion is 2022-10-24.
What interventions are being tested in trial NCT03875131?
The interventions under investigation include: Biomarkers of Dementia and Cognitive Decline (OTHER).
Who is sponsoring clinical trial NCT03875131?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI